| (-)-epigallocatechin 3-gallate | decreases expression | EXP | | 6480464 | epigallocatechin gallate results in decreased expression of BAK1 mRNA | CTD | PMID:18851785 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:621635 | 6480464 | Ethinyl Estradiol results in increased expression of BAK1 mRNA | CTD | PMID:17557909 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of BAK1 mRNA | CTD | PMID:23373633 |
| 1H-pyrazole | multiple interactions | ISO | RGD:621635 | 6480464 | [Ethanol co-treated with pyrazole co-treated with Carbon Tetrachloride] results in increased expression of BAK1 mRNA | CTD | PMID:16610055 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:621635 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BAK1 mRNA | CTD | PMID:19520675 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1552456 | 6480464 | Tetrachlorodibenzodioxin affects the expression of BAK1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:621635 | 6480464 | Tetrachlorodibenzodioxin affects the expression of BAK1 mRNA | CTD | PMID:22298810 |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | ISO | RGD:621635 | 6480464 | Losartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BAK1 mRNA] | CTD | PMID:15502641 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | RGD:621635 | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of BAK1 mRNA | CTD | PMID:15502641 |
| 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:1552456 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of BAK1 mRNA | CTD | PMID:18648102 |
| 4-hydroxyphenyl retinamide | increases expression | EXP | | 6480464 | Fenretinide results in increased expression of BAK1 protein | CTD | PMID:17273769 |
| 5-aza-2'-deoxycytidine | increases expression | EXP | | 6480464 | decitabine results in increased expression of BAK1 mRNA | CTD | PMID:17908484 |
| 5-azacytidine | increases expression | EXP | | 6480464 | Azacitidine results in increased expression of BAK1 mRNA | CTD | PMID:15547111 |
| 5-fluorouracil | increases expression | EXP | | 6480464 | Fluorouracil results in increased expression of BAK1 | CTD | PMID:9792140 |
| 5-fluorouracil | multiple interactions | EXP | | 6480464 | mithramycin A inhibits the reaction [Fluorouracil results in increased expression of BAK1 protein] | CTD | PMID:15489892 |
| 5-fluorouracil | increases expression | EXP | | 6480464 | Fluorouracil results in increased expression of BAK1 protein | CTD | PMID:15489892 |
| 5-fluorouracil | increases response to substance | EXP | | 6480464 | BAK1 mRNA results in increased susceptibility to Fluorouracil | CTD | PMID:18593893 |
| 5-fluorouracil | increases expression | EXP | | 6480464 | Fluorouracil results in increased expression of BAK1 mRNA | CTD | PMID:16557594 |
| acetylsalicylic acid | increases expression | EXP | | 6480464 | Aspirin results in increased expression of BAK1 protein | CTD | PMID:11532860 |
| actinomycin D | multiple interactions | ISO | RGD:621635 | 6480464 | Dactinomycin inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of BAK1 mRNA] | CTD | PMID:21281706 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of BAK1 mRNA | CTD | PMID:22100608 |
| alantolactone | increases expression | EXP | | 6480464 | alantolactone results in increased expression of BAK1 protein | CTD | PMID:22721982 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [Melatonin co-treated with Tretinoin] results in increased expression of BAK1 protein | CTD | PMID:10965999 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of BAK1 mRNA | CTD | PMID:15498508 PMID:15894607 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of BAK1 mRNA | CTD | PMID:15498508 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of BAK1 protein | CTD | PMID:16778211 |
| aluminium trichloride | affects response to substance | EXP | | 6480464 | BAK1 protein affects the susceptibility to aluminum chloride | CTD | PMID:19740541 |
| ammonium chloride | affects expression | ISO | RGD:621635 | 6480464 | Ammonium Chloride affects the expression of BAK1 mRNA | CTD | PMID:16483693 |
| arsenite(3-) | increases activity | EXP | | 6480464 | arsenite results in increased activity of BAK1 protein | CTD | PMID:17553788 |
| auranofin | multiple interactions | ISO | RGD:1552456 | 6480464 | BAK1 mutant form inhibits the reaction [Auranofin results in increased activity of CASP3 protein] | CTD | PMID:18789312 |
| auranofin | multiple interactions | ISO | RGD:1552456 | 6480464 | [BAX co-treated with BAK1] results in increased susceptibility to Auranofin | CTD | PMID:21172426 |
| auranofin | increases response to substance | ISO | RGD:1552456 | 6480464 | BAK1 results in increased susceptibility to Auranofin | CTD | PMID:18789312 |
| bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of BAK1 protein | CTD | PMID:21277958 |
| capsaicin | increases activity | ISO | RGD:1552456 | 6480464 | Capsaicin results in increased activity of BAK1 protein | CTD | PMID:17295509 |
| capsaicin | increases expression | EXP | | 6480464 | Capsaicin results in increased expression of BAK1 mRNA | CTD | PMID:19502594 |
| cefaloridine | increases expression | ISO | RGD:621635 | 6480464 | Cephaloridine results in increased expression of BAK1 mRNA | CTD | PMID:18500788 |
| celecoxib | increases expression | EXP | | 6480464 | celecoxib analog results in increased expression of BAK1 protein; more ... | CTD | PMID:19682443 |
| celecoxib | increases expression | EXP | | 6480464 | celecoxib results in increased expression of BAK1 protein | CTD | PMID:19428934 PMID:19682443 |
| celecoxib | increases expression | EXP | | 6480464 | celecoxib results in increased expression of BAK1 mRNA | CTD | PMID:19428934 |
| celecoxib | increases expression | EXP | | 6480464 | celecoxib results in increased expression of BAK1 protein | CTD | PMID:19682443 PMID:19428934 |
| celecoxib | decreases response to substance | ISO | RGD:621635 | 6480464 | BAK1 results in decreased susceptibility to celecoxib | CTD | PMID:18349538 |
| cisplatin | multiple interactions | ISO | RGD:1552456 | 6480464 | [BAX co-treated with BAK1] results in increased susceptibility to Cisplatin | CTD | PMID:21172426 |
| cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with fisetin] results in increased expression of BAK1 protein | CTD | PMID:21216935 |
| copper atom | multiple interactions | ISO | RGD:621635 | 6480464 | Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased expression of BAK1 mRNA]; more ... | CTD | PMID:22085843 |
| copper(0) | multiple interactions | ISO | RGD:621635 | 6480464 | Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased expression of BAK1 mRNA]; more ... | CTD | PMID:22085843 |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of BAK1 mRNA | CTD | PMID:17332930 |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of BAK1 protein | CTD | PMID:17332930 PMID:18226269 |
| curcumin | increases response to substance | ISO | RGD:1552456 | 6480464 | BAK1 protein results in increased susceptibility to Curcumin | CTD | PMID:17277231 |
| curcumin | increases expression | ISO | RGD:1552456 | 6480464 | Curcumin results in increased expression of BAK1 protein | CTD | PMID:17277231 |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of BAK1 protein | CTD | PMID:18226269 PMID:17332930 |
| curcumin | multiple interactions | EXP | | 6480464 | TNFSF10 protein promotes the reaction [Curcumin results in increased expression of BAK1 protein] | CTD | PMID:18226269 |
| DDE | multiple interactions | ISO | RGD:621635 | 6480464 | Dactinomycin inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of BAK1 mRNA] | CTD | PMID:21281706 |
| DDE | increases expression | ISO | RGD:621635 | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of BAK1 mRNA | CTD | PMID:21281706 PMID:21384494 |
| DDE | increases expression | ISO | RGD:621635 | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of BAK1 mRNA | CTD | PMID:21281706 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of BAK1 mRNA; more ... | CTD | PMID:19428934 |
| diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of BAK1 mRNA | CTD | PMID:17530438 |
| diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of BAK1 mRNA | CTD | PMID:11940349 PMID:17530438 |
| diarsenic trioxide | affects response to substance | ISO | RGD:1552456 | 6480464 | BAK1 protein affects the susceptibility to arsenic trioxide | CTD | PMID:15979664 |
| diarsenic trioxide | decreases expression | ISO | RGD:621635 | 6480464 | arsenic trioxide results in decreased expression of BAK1 mRNA | CTD | PMID:19730151 |
| diclofenac | increases activity | EXP | | 6480464 | Diclofenac results in increased activity of BAK1 protein | CTD | PMID:18191430 |
| diepoxybutane | increases expression | EXP | | 6480464 | erythritol anhydride results in increased expression of BAK1 | CTD | PMID:17693053 |
| disodium selenite | increases expression | EXP | | 6480464 | Sodium Selenite results in increased expression of BAK1 mRNA | CTD | PMID:16705456 |
| docetaxel anhydrous | multiple interactions | EXP | | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [docetaxel results in increased activity of BAK1 protein]; more ... | CTD | PMID:17317842 |
| docetaxel anhydrous | increases activity | EXP | | 6480464 | docetaxel results in increased activity of BAK1 protein | CTD | PMID:17317842 |
| docetaxel anhydrous | multiple interactions | EXP | | 6480464 | benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [docetaxel affects the folding of and results in increased activity of BAK1 protein]; more ... | CTD | PMID:17308071 |
| doxorubicin | decreases response to substance | EXP | | 6480464 | BAK1 protein results in decreased susceptibility to Doxorubicin | CTD | PMID:11313874 |
| doxorubicin | increases activity | EXP | | 6480464 | Doxorubicin results in increased activity of BAK1 protein | CTD | PMID:15917298 |
| doxorubicin | multiple interactions | EXP | | 6480464 | benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [Doxorubicin results in increased activity of BAK1 protein]; more ... | CTD | PMID:15917298 |
| ethanol | multiple interactions | ISO | RGD:621635 | 6480464 | [Ethanol co-treated with pyrazole co-treated with Carbon Tetrachloride] results in increased expression of BAK1 mRNA | CTD | PMID:16610055 |
| etoposide | increases activity | EXP | | 6480464 | Etoposide results in increased activity of BAK1 protein | CTD | PMID:21745461 |
| etoposide | affects response to substance | ISO | RGD:1552456 | 6480464 | BAK1 protein affects the susceptibility to Etoposide | CTD | PMID:16077961 |
| etoposide | multiple interactions | EXP | | 6480464 | nimesulide inhibits the reaction [Etoposide results in increased activity of BAK1 protein] | CTD | PMID:21745461 |
| etoposide | affects expression | EXP | | 6480464 | Etoposide affects the expression of BAK1 protein | CTD | PMID:15215046 |
| fisetin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with fisetin] results in increased expression of BAK1 protein | CTD | PMID:21216935 |
| fonofos | increases methylation | EXP | | 6480464 | Fonofos results in increased methylation of BAK1 promoter | CTD | PMID:22847954 |
| furan | increases expression | ISO | RGD:621635 | 6480464 | furan results in increased expression of BAK1 mRNA | CTD | PMID:22079235 |
| furosemide | affects expression | ISO | RGD:621635 | 6480464 | Furosemide affects the expression of BAK1 mRNA | CTD | PMID:17497460 |
| gold atom | increases expression | EXP | | 6480464 | Gold results in increased expression of BAK1 mRNA | CTD | PMID:22178767 |
| gold(0) | increases expression | EXP | | 6480464 | Gold results in increased expression of BAK1 mRNA | CTD | PMID:22178767 |
| hydrogen peroxide | decreases expression | EXP | | 6480464 | Hydrogen Peroxide results in decreased expression of BAK1 mRNA | CTD | PMID:12419474 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of BAK1 protein | CTD | PMID:11532860 |
| indomethacin | multiple interactions | ISO | RGD:621635 | 6480464 | Melatonin inhibits the reaction [Indomethacin results in increased expression of BAK1 mRNA] | CTD | PMID:19220725 |
| indomethacin | increases expression | ISO | RGD:621635 | 6480464 | Indomethacin results in increased expression of BAK1 protein | CTD | PMID:18375387 |
| indomethacin | increases expression | ISO | RGD:621635 | 6480464 | Indomethacin results in increased expression of BAK1 mRNA | CTD | PMID:19220725 |
| isoflurane | decreases expression | ISO | RGD:621635 | 6480464 | Isoflurane results in decreased expression of BAK1 mRNA | CTD | PMID:16978161 |
| lansoprazole | increases expression | ISO | RGD:621635 | 6480464 | lansoprazole results in increased expression of BAK1 protein | CTD | PMID:18375387 |
| lithocholic acid | multiple interactions | ISO | RGD:1552456 | 6480464 | [Lithocholic Acid co-treated with Phenobarbital] results in decreased expression of BAK1 protein; more ... | CTD | PMID:19433268 |
| losartan | multiple interactions | ISO | RGD:621635 | 6480464 | Losartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BAK1 mRNA] | CTD | PMID:15502641 |
| melatonin | multiple interactions | EXP | | 6480464 | [Melatonin co-treated with Tretinoin] results in increased expression of BAK1 protein | CTD | PMID:10965999 |
| melatonin | multiple interactions | ISO | RGD:621635 | 6480464 | Melatonin inhibits the reaction [Indomethacin results in increased expression of BAK1 mRNA] | CTD | PMID:19220725 |
| menadione | affects expression | EXP | | 6480464 | Vitamin K 3 affects the expression of BAK1 mRNA | CTD | PMID:20044591 |
| minocycline | multiple interactions | ISO | RGD:621635 | 6480464 | [Minocycline results in increased expression of BCL2 protein] which binds to BAK1 protein | CTD | PMID:15004018 |
| morphine | increases expression | EXP | | 6480464 | Morphine results in increased expression of BAK1 protein | CTD | PMID:19070643 |
| mycophenolate mofetil | increases expression | EXP | | 6480464 | mycophenolate mofetil results in increased expression of BAK1 protein | CTD | PMID:16505121 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1552456 | 6480464 | Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of BAK1 mRNA] | CTD | PMID:21549813 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:621635 | 6480464 | Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased expression of BAK1 mRNA]; more ... | CTD | PMID:22085843 |
| nickel dichloride | increases expression | ISO | RGD:621635 | 6480464 | nickel chloride results in increased expression of BAK1 mRNA | CTD | PMID:21843586 |
| nimesulide | multiple interactions | EXP | | 6480464 | nimesulide inhibits the reaction [Etoposide results in increased activity of BAK1 protein] | CTD | PMID:21745461 |
| nimesulide | decreases response to substance | ISO | RGD:621635 | 6480464 | BAK1 results in decreased susceptibility to nimesulide | CTD | PMID:18349538 |
| ochratoxin A | increases expression | ISO | RGD:621635 | 6480464 | ochratoxin A results in increased expression of BAK1 mRNA | CTD | PMID:23358140 |
| paclitaxel | affects expression | EXP | | 6480464 | Paclitaxel affects the expression of BAK1 protein; more ... | CTD | PMID:10822281 |
| paclitaxel | multiple interactions | ISO | RGD:1552456 | 6480464 | [BAK1 protein mutant form co-treated with BAX protein mutant form] inhibits the reaction [Paclitaxel results in increased activity of and results in increased cleavage of CASP3 protein] | CTD | PMID:17652622 |
| paclitaxel | increases expression | EXP | | 6480464 | Paclitaxel results in increased expression of BAK1 mRNA; more ... | CTD | PMID:10822281 |
| paracetamol | affects expression | ISO | RGD:1552456 | 6480464 | Acetaminophen affects the expression of BAK1 mRNA | CTD | PMID:17562736 |
| paracetamol | multiple interactions | ISO | RGD:1552456 | 6480464 | dioscin inhibits the reaction [Acetaminophen results in increased expression of BAK1 protein] | CTD | PMID:22939915 |
| paracetamol | increases expression | ISO | RGD:1552456 | 6480464 | Acetaminophen results in increased expression of BAK1 protein | CTD | PMID:22939915 |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of BAK1 mRNA | CTD | PMID:22230393 |
| paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of BAK1 mRNA | CTD | PMID:18836921 |
| paraquat | multiple interactions | ISO | RGD:621635 | 6480464 | NFE2L2 mutant form inhibits the reaction [Paraquat results in increased expression of BAK1 mRNA] | CTD | PMID:22678742 |
| paraquat | increases expression | ISO | RGD:621635 | 6480464 | Paraquat results in increased expression of BAK1 mRNA; more ... | CTD | PMID:22678742 |
| parathion | increases methylation | EXP | | 6480464 | Parathion results in increased methylation of BAK1 promoter | CTD | PMID:22847954 |
| phenobarbital | multiple interactions | ISO | RGD:1552456 | 6480464 | [Lithocholic Acid co-treated with Phenobarbital] results in decreased expression of BAK1 protein | CTD | PMID:19433268 |
| phorbol 13-acetate 12-myristate | increases expression | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of BAK1 protein | CTD | PMID:11139146 |
| pregnenolone 16alpha-carbonitrile | multiple interactions | ISO | RGD:1552456 | 6480464 | [Lithocholic Acid co-treated with Pregnenolone Carbonitrile] results in decreased expression of BAK1 protein | CTD | PMID:19433268 |
| pterostilbene | increases expression | EXP | | 6480464 | pterostilbene results in increased expression of BAK1 protein | CTD | PMID:23313376 |
| quercetin | increases expression | EXP | | 6480464 | Quercetin metabolite results in increased expression of BAK1 protein | CTD | PMID:16280456 |
| quercetin | increases expression | ISO | RGD:1552456 | 6480464 | Quercetin results in increased expression of BAK1 protein | CTD | PMID:17039455 |
| raloxifene | decreases expression | EXP | | 6480464 | Raloxifene results in decreased expression of BAK1 mRNA | CTD | PMID:16202921 |
| resveratrol | increases response to substance | EXP | | 6480464 | BAK1 protein results in increased susceptibility to resveratrol | CTD | PMID:16550006 |
| resveratrol | increases activity | EXP | | 6480464 | resveratrol results in increased activity of BAK1 protein | CTD | PMID:22245142 |
| resveratrol | increases response to substance | EXP | | 6480464 | BAK1 protein results in increased susceptibility to resveratrol | CTD | PMID:16550006 PMID:22245142 |
| resveratrol | multiple interactions | EXP | | 6480464 | BAK1 protein promotes the reaction [resveratrol results in increased secretion of AIFM1 protein]; more ... | CTD | PMID:22245142 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of BAK1 mRNA | CTD | PMID:12002526 PMID:12569576 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of BAK1 protein | CTD | PMID:16731767 PMID:17636462 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of BAK1 mRNA | CTD | PMID:12569576 PMID:12002526 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of BAK1 protein | CTD | PMID:17636462 PMID:16731767 |
| resveratrol | affects folding | EXP | | 6480464 | resveratrol affects the folding of BAK1 protein | CTD | PMID:16617056 |
| resveratrol | multiple interactions | EXP | | 6480464 | CASP2 protein affects the reaction [resveratrol affects the folding of BAK1 protein] | CTD | PMID:16617056 |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of BAK1 mRNA | CTD | PMID:17639046 |
| sulindac | affects localization | EXP | | 6480464 | Sulindac affects the localization of BAK1 protein | CTD | PMID:17136320 |
| sulindac | multiple interactions | EXP | | 6480464 | SB 203580 inhibits the reaction [Sulindac affects the localization of BAK1 protein] | CTD | PMID:17136320 |
| tamibarotene | increases expression | EXP | | 6480464 | Am 80 results in increased expression of BAK1 mRNA; more ... | CTD | PMID:15498508 |
| terbufos | increases methylation | EXP | | 6480464 | terbufos results in increased methylation of BAK1 promoter | CTD | PMID:22847954 |
| tert-butyl hydroperoxide | decreases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in decreased expression of BAK1 mRNA | CTD | PMID:12419474 |
| tetrachloromethane | multiple interactions | ISO | RGD:621635 | 6480464 | [Ethanol co-treated with pyrazole co-treated with Carbon Tetrachloride] results in increased expression of BAK1 mRNA | CTD | PMID:16610055 |
| trans-resveratrol | increases response to substance | EXP | | 6480464 | BAK1 protein results in increased susceptibility to resveratrol | CTD | PMID:16550006 |
| trans-resveratrol | increases activity | EXP | | 6480464 | resveratrol results in increased activity of BAK1 protein | CTD | PMID:22245142 |
| trans-resveratrol | increases response to substance | EXP | | 6480464 | BAK1 protein results in increased susceptibility to resveratrol | CTD | PMID:16550006 PMID:22245142 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | BAK1 protein promotes the reaction [resveratrol results in increased secretion of AIFM1 protein]; more ... | CTD | PMID:22245142 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of BAK1 mRNA | CTD | PMID:12002526 PMID:12569576 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of BAK1 protein | CTD | PMID:16731767 PMID:17636462 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of BAK1 mRNA | CTD | PMID:12569576 PMID:12002526 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of BAK1 protein | CTD | PMID:17636462 PMID:16731767 |
| trans-resveratrol | affects folding | EXP | | 6480464 | resveratrol affects the folding of BAK1 protein | CTD | PMID:16617056 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | CASP2 protein affects the reaction [resveratrol affects the folding of BAK1 protein] | CTD | PMID:16617056 |
| trichostatin A | multiple interactions | EXP | | 6480464 | [D 21266 co-treated with trichostatin A] results in decreased expression of BAK1 protein; more ... | CTD | PMID:15781658 |
| trimellitic anhydride | increases expression | ISO | RGD:1552456 | 6480464 | trimellitic anhydride results in increased expression of BAK1 mRNA | CTD | PMID:19042947 |
| tunicamycin | increases activity | EXP | | 6480464 | Tunicamycin results in increased activity of BAK1 protein | CTD | PMID:17553788 |
| urethane | multiple interactions | ISO | RGD:1552456 | 6480464 | [Urethane co-treated with Freund's Adjuvant] results in increased expression of BAK1 mRNA | CTD | PMID:12400877 |
| ursolic acid | increases activity | EXP | | 6480464 | ursolic acid results in increased activity of BAK1 protein | CTD | PMID:20630652 |
| valproic acid | increases expression | ISO | RGD:1552456 | 6480464 | Valproic Acid results in increased expression of BAK1 mRNA | CTD | PMID:21427059 |
| valproic acid | decreases expression | ISO | RGD:1552456 | 6480464 | Valproic Acid results in decreased expression of BAK1 mRNA | CTD | PMID:21427059 |
| vincristine | affects response to substance | EXP | | 6480464 | BAK1 protein affects the susceptibility to Vincristine | CTD | PMID:22178383 |